BCR and neoplasm: Intriguingly, our GSEA data indicated that the B cell receptor (BCR) and T cell receptor (TCR) signaling pathways were enriched in the MGSlow subgroup, which indicated that anti-tumor immune status may be attenuated in the MGShigh subgroup (61–63).